Natural Human Immunity Against Staphylococcal Protein A Relies on Effector Functions Triggered by IgG3

Staphylococcal protein A (SpA) is a multifunctional, highly conserved virulence factor of Staphylococcus aureus. By binding the Fc portion of all human IgG subclasses apart from IgG3, SpA interferes with antibody and complement deposition on the bacterial surface, impairing staphylococcal clearance by phagocytosis. Because of its anti-opsonic properties, SpA is not investigated as a surface antigen to mediate bacterial phagocytosis. Herein we investigate human sera for the presence of SpA-opsonizing antibodies. The screening revealed that sera containing IgG3 against SpA were able to correctly opsonize the target and drive Fcγ receptor-mediated interactions and phagocytosis. We demonstrated that IgG3 Fc is significantly more efficient in inducing phagocytosis of SpA-expressing S. aureus as compared to IgG1 Fc in an assay resembling physiological conditions. Furthermore, we show that the capacity of SpA antibodies to induce phagocytosis depends on the specific epitope recognized by the IgGs on SpA molecules. Overall, our results suggest that anti-SpA IgG3 antibodies could favor the anti-staphylococcal response in humans, paving the way towards the identification of a correlate of protection against staphylococcal infections.

[1]  D. Fenyö,et al.  Diversity of Functionally Distinct Clonal Sets of Human Conventional Memory B Cells That Bind Staphylococcal Protein A , 2021, Frontiers in Immunology.

[2]  J. V. van Strijp,et al.  Use of Flow Cytometry to Evaluate Phagocytosis of Staphylococcus aureus by Human Neutrophils , 2021, Frontiers in Immunology.

[3]  E. Patz,et al.  Coming together at the hinges: Therapeutic prospects of IgG3 , 2021, mAbs.

[4]  P. Proost,et al.  Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis , 2021, Frontiers in Cell and Developmental Biology.

[5]  P. Parren,et al.  C1q binding to surface-bound IgG is stabilized by C1r2s2 proteases , 2021, Proceedings of the National Academy of Sciences.

[6]  A. Heck,et al.  Staphylococcal protein A inhibits complement activation by interfering with IgG hexamer formation , 2020, Proceedings of the National Academy of Sciences.

[7]  Feng Yang,et al.  Rapid and Broad Immune Efficacy of a Recombinant Five-Antigen Vaccine against Staphylococcus aureus Infection in Animal Models , 2020, Vaccines.

[8]  F. Jönsson,et al.  Expression, Role, and Regulation of Neutrophil Fcγ Receptors , 2019, Front. Immunol..

[9]  V. Scarlato,et al.  Absence of Protein A Expression Is Associated With Higher Capsule Production in Staphylococcal Isolates , 2019, Front. Microbiol..

[10]  K. Pardesi,et al.  Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review , 2019, Front. Microbiol..

[11]  E. Bartolini,et al.  Retrospective Identification of a Broad IgG Repertoire Differentiating Patients With S. aureus Skin and Soft Tissue Infections From Controls , 2019, Front. Immunol..

[12]  D. Missiakas,et al.  Staphylococcus aureus Decolonization of Mice With Monoclonal Antibody Neutralizing Protein A , 2018, The Journal of infectious diseases.

[13]  R. Barker,et al.  Similarities and differences in surface receptor expression by THP-1 monocytes and differentiated macrophages polarized using seven different conditioning regimens. , 2018, Cellular immunology.

[14]  G. Silverman,et al.  Essential Domain-Dependent Roles Within Soluble IgG for in vivo Superantigen Properties of Staphylococcal Protein A: Resolving the B-Cell Superantigen Paradox , 2018, Front. Immunol..

[15]  Sahreena S. Lakhundi,et al.  Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology , 2018, Clinical Microbiology Reviews.

[16]  S. Shivaswamy,et al.  A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia , 2018, PloS one.

[17]  J. Voyich,et al.  Epic Immune Battles of History: Neutrophils vs. Staphylococcus aureus , 2017, Front. Cell. Infect. Microbiol..

[18]  S. Enany,et al.  The Rise of Virulence and Antibiotic Resistance in Staphylococcus aureus , 2017 .

[19]  M. Cancino-Diaz,et al.  Surface Proteins of Staphylococcus aureus , 2017 .

[20]  R. Tisch,et al.  Staphylococcus aureus Protein A Disrupts Immunity Mediated by Long-Lived Plasma Cells , 2017, The Journal of Immunology.

[21]  Sang J. Chung,et al.  Fc-Binding Ligands of Immunoglobulin G: An Overview of High Affinity Proteins and Peptides , 2016, Materials.

[22]  V. Masignani,et al.  Exploring host-pathogen interactions through genome wide protein microarray analysis , 2016, Scientific Reports.

[23]  M. O’Shea,et al.  Population variation in anti-S. aureus IgG isotypes influences surface protein A mediated immune subversion. , 2016, Vaccine.

[24]  F. DeLeo,et al.  Evasion of Neutrophil Killing by Staphylococcus aureus , 2016, Pathogens.

[25]  J. Geoghegan,et al.  The Role of Staphylococcus aureus Virulence Factors in Skin Infection and Their Potential as Vaccine Antigens , 2016, Pathogens.

[26]  M. Pekna,et al.  Deficiency of the Complement Component 3 but Not Factor B Aggravates Staphylococcus aureus Septic Arthritis in Mice , 2016, Infection and Immunity.

[27]  Vance G. Fowler,et al.  Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management , 2015, Clinical Microbiology Reviews.

[28]  D. Missiakas,et al.  Protein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus. , 2015, Vaccine.

[29]  Mallary C Greenlee-Wacker,et al.  How methicillin-resistant Staphylococcus aureus evade neutrophil killing , 2015, Current opinion in hematology.

[30]  P. Wilson,et al.  Staphylococcus aureus infection induces protein A–mediated immune evasion in humans , 2014, The Journal of experimental medicine.

[31]  Gillian Dekkers,et al.  IgG Subclasses and Allotypes: From Structure to Effector Functions , 2014, Front. Immunol..

[32]  J. V. van Strijp,et al.  Neutrophil-Mediated Phagocytosis of Staphylococcus aureus , 2014, Front. Immunol..

[33]  Piet Gros,et al.  Complement Is Activated by IgG Hexamers Assembled at the Cell Surface , 2014, Science.

[34]  J. B. Wardenburg,et al.  Igniting the Fire: Staphylococcus aureus Virulence Factors in the Pathogenesis of Sepsis , 2014, PLoS pathogens.

[35]  T. Rogers,et al.  Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design , 2014, Front. Immunol..

[36]  R. Nijland,et al.  Neutrophils versus Staphylococcus aureus: a biological tug of war. , 2013, Annual review of microbiology.

[37]  D. Missiakas,et al.  Role of Protein A in the Evasion of Host Adaptive Immune Responses by Staphylococcus aureus , 2013, mBio.

[38]  A. Collins,et al.  A Temporal Model of Human IgE and IgG Antibody Function , 2013, Front. Immunol..

[39]  R. Nijland,et al.  Studying interactions of Staphylococcus aureus with neutrophils by flow cytometry and time lapse microscopy. , 2013, Journal of visualized experiments : JoVE.

[40]  P. Hogan,et al.  A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  D. Missiakas,et al.  Protein A-Specific Monoclonal Antibodies and Prevention of Staphylococcus aureus Disease in Mice , 2012, Infection and Immunity.

[42]  B. Spellberg,et al.  Progress toward a Staphylococcus aureus vaccine. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  K. Rigby,et al.  Neutrophils in innate host defense against Staphylococcus aureus infections , 2011, Seminars in Immunopathology.

[44]  T. Solov’eva,et al.  IgG-binding proteins of bacteria , 2011, Biochemistry (Moscow).

[45]  D. Missiakas,et al.  Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice , 2010, The Journal of experimental medicine.

[46]  A. Hofman,et al.  Induction of antibodies by Staphylococcus aureus nasal colonization in young children. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[47]  L. Cavacini,et al.  Structure and function of immunoglobulins. , 2010, The Journal of allergy and clinical immunology.

[48]  H. Takada,et al.  Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome , 2009, The Journal of experimental medicine.

[49]  F. DeLeo,et al.  Host defense and pathogenesis in Staphylococcus aureus infections. , 2009, Infectious disease clinics of North America.

[50]  Alex van Belkum,et al.  Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. , 2009, The Journal of infectious diseases.

[51]  S. Diamond,et al.  Neutrophil Isolation Protocol , 2008, Journal of visualized experiments : JoVE.

[52]  Bharat Reddy,et al.  Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1 , 2004, Nature Medicine.

[53]  Johannes Söllner,et al.  Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J J Sixma,et al.  Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. , 2000, Blood.

[55]  P. Parren,et al.  The IgG Fc Contains Distinct Fc Receptor (FcR) Binding Sites: The Leukocyte Receptors FcγRI and FcγRIIa Bind to a Region in the Fc Distinct from That Recognized by Neonatal FcR and Protein A1 , 2000, The Journal of Immunology.

[56]  M. Taussig,et al.  Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[57]  L. Jendeberg,et al.  Engineering of Fc(1) and Fc(3) from human immunoglobulin G to analyse subclass specificity for staphylococcal protein A. , 1997, Journal of immunological methods.

[58]  T. Out,et al.  Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. , 1994, Immunology.

[59]  A. Cheung,et al.  Surface proteins of Staphylococcus aureus. , 1988, Reviews of infectious diseases.

[60]  L. Björck,et al.  A physicochemical study of protein G, a molecule with unique immunoglobulin G-binding properties. , 1986, The Journal of biological chemistry.

[61]  B. Frangione,et al.  Staphylococcal Protein A and Human IgG Subclasses and Allotypes , 1982, Scandinavian journal of immunology.

[62]  J. Deisenhofer.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[63]  J. Verhoef,et al.  Effect of protein A on staphylococcal opsonization , 1977, Infection and immunity.

[64]  R. Williams,et al.  Antiphagocytic effects of staphylococcal protein A. , 1969, Journal of immunology.

[65]  The Complement System: Innovative Diagnostic and Research Protocols , 2021 .

[66]  Simone Magnoni,et al.  Method for Depletion of IgG and IgM from Human Serum as Naive Complement Source. , 2021, Methods in molecular biology.

[67]  D. Zenkert,et al.  Functional Composites and Structures , 2019 .

[68]  Sofia Nohldén.  Affinity Determination of Protein A Domains to IgG subclasses by Surface Plasmon Resonance , 2008 .